Found: 136
Select item for more details and to access through your institution.
Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 8, p. 1, doi. 10.1007/s00403-024-03319-z
- By:
- Publication type:
- Article
Correlation of atopic dermatitis with measurement tools in Korean patients: A retrospective study.
- Published in:
- 2020
- By:
- Publication type:
- letter
The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy—report of two cases and review of the literature.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. 2, p. 631
- By:
- Publication type:
- Article
Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192443
- By:
- Publication type:
- Article
Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition.
- Published in:
- Allergy, 2023, v. 78, n. 11, p. 2875, doi. 10.1111/all.15811
- By:
- Publication type:
- Article
Validation of a novel patient‐operated device for measuring skin barrier function in atopic dermatitis.
- Published in:
- Skin Research & Technology, 2021, v. 27, n. 5, p. 824, doi. 10.1111/srt.13027
- By:
- Publication type:
- Article
Validation of a novel smartphone application‐enabled, patient‐operated skin barrier device.
- Published in:
- Skin Research & Technology, 2019, v. 25, n. 5, p. 612, doi. 10.1111/srt.12692
- By:
- Publication type:
- Article
Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate‐to‐severe disease.
- Published in:
- Experimental Dermatology, 2021, v. 30, n. 11, p. 1650, doi. 10.1111/exd.14389
- By:
- Publication type:
- Article
Sequelae of World War II: An Outbreak of Chronic Cutaneous Nontuberculous Mycobacterial Infection among Satowanese Islanders.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 11, p. 1541, doi. 10.1086/598928
- By:
- Publication type:
- Article
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2139, doi. 10.1007/s13555-024-01219-8
- By:
- Publication type:
- Article
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2285, doi. 10.1007/s13555-024-01200-5
- By:
- Publication type:
- Article
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1145, doi. 10.1007/s13555-024-01158-4
- By:
- Publication type:
- Article
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1127, doi. 10.1007/s13555-024-01157-5
- By:
- Publication type:
- Article
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 261, doi. 10.1007/s13555-023-01061-4
- By:
- Publication type:
- Article
History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 10, p. 2417, doi. 10.1007/s13555-023-00996-y
- By:
- Publication type:
- Article
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1987, doi. 10.1007/s13555-023-00960-w
- By:
- Publication type:
- Article
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1893, doi. 10.1007/s13555-023-00948-6
- By:
- Publication type:
- Article
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS).
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 12, p. 2817, doi. 10.1007/s13555-022-00836-5
- By:
- Publication type:
- Article
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 9, doi. 10.1007/s13555-021-00657-y
- By:
- Publication type:
- Article
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 195, doi. 10.1007/s13555-021-00643-4
- By:
- Publication type:
- Article
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 137, doi. 10.1007/s13555-021-00640-7
- By:
- Publication type:
- Article
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 223, doi. 10.1007/s13555-021-00638-1
- By:
- Publication type:
- Article
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1643, doi. 10.1007/s13555-021-00568-y
- By:
- Publication type:
- Article
Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 4, p. 1415, doi. 10.1007/s13555-021-00543-7
- By:
- Publication type:
- Article
Relationship Among Treatment, Pruritus, Investigator's Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 2, p. 587, doi. 10.1007/s13555-021-00506-y
- By:
- Publication type:
- Article
Correction to: Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 2, p. 297, doi. 10.1007/s13555-020-00356-0
- By:
- Publication type:
- Article
Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 4, p. 799, doi. 10.1007/s13555-019-00333-2
- By:
- Publication type:
- Article
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 4, p. 605, doi. 10.1007/s13555-018-0263-0
- By:
- Publication type:
- Article
Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2653, doi. 10.1007/s11095-023-03616-8
- By:
- Publication type:
- Article
Cell Death-Induced Activation of Epidermal Growth Factor Receptor in Keratinocytes: Implications for Restricting Epidermal Damage in Dermatitis.
- Published in:
- Journal of Investigative Dermatology, 2005, v. 125, n. 1, p. 134, doi. 10.1111/j.0022-202X.2005.23804.x
- By:
- Publication type:
- Article
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 3, p. 928, doi. 10.1007/s12325-023-02755-z
- By:
- Publication type:
- Article
Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 4, p. 753, doi. 10.1002/jvc2.203
- By:
- Publication type:
- Article
Efficacy of dupilumab in moderate and severe atopic dermatitis.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 247, doi. 10.1002/jvc2.100
- By:
- Publication type:
- Article
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reversion of Methicillin-Resistant Staphylococcus aureus Skin Infections to Methicillin-Susceptible Isolates.
- Published in:
- JAMA Dermatology, 2013, v. 149, n. 10, p. 1167, doi. 10.1001/jamadermatol.2013.4909
- By:
- Publication type:
- Article
Triple antibiotic combination therapy may improve but not resolve granuloma annulare.
- Published in:
- Dermatologic Therapy, 2014, v. 27, n. 6, p. 343, doi. 10.1111/dth.12159
- By:
- Publication type:
- Article
The effects of treatment on itch in atopic dermatitis.
- Published in:
- Dermatologic Therapy, 2013, v. 26, n. 2, p. 110, doi. 10.1111/dth.12032
- By:
- Publication type:
- Article
Atopic dermatitis prevention.
- Published in:
- Dermatologic Therapy, 2006, v. 19, n. 2, p. 108, doi. 10.1111/j.1529-8019.2006.00059.x
- By:
- Publication type:
- Article
Patterns of care and referral in children with atopic dermatitis and concern for food allergy.
- Published in:
- Dermatologic Therapy, 2006, v. 19, n. 2, p. 91, doi. 10.1111/j.1529-8019.2006.00062.x
- By:
- Publication type:
- Article
Skincare interventions in infants for preventing eczema and food allergy: A cochrane systematic review and individual participant data meta‐analysis.
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 3, p. 402, doi. 10.1111/cea.13847
- By:
- Publication type:
- Article
A survey in uncharted territory: A collaborative study to explore the approach to atopic dermatitis patient management in allopathy and naturopathy.
- Published in:
- Pediatric Dermatology, 2020, v. 37, n. 1, p. 109, doi. 10.1111/pde.14036
- By:
- Publication type:
- Article
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry.
- Published in:
- Pediatric Dermatology, 2018, v. 35, n. 3, p. 303, doi. 10.1111/pde.13452
- By:
- Publication type:
- Article
Validation of a Parent-Reported Diagnostic Instrument in a U.S. Referral Population: The Childhood Eczema Questionnaire.
- Published in:
- Pediatric Dermatology, 2017, v. 34, n. 4, p. 398, doi. 10.1111/pde.13139
- By:
- Publication type:
- Article
Market Trends in Baby Skin Care Products and Implications for Clinical Practice.
- Published in:
- Pediatric Dermatology, 2014, v. 31, n. 6, p. 734, doi. 10.1111/pde.12424
- By:
- Publication type:
- Article
Do Early Skin Care Practices Alter the Risk of Atopic Dermatitis? A Case-Control Study.
- Published in:
- Pediatric Dermatology, 2011, v. 28, n. 5, p. 593, doi. 10.1111/j.1525-1470.2011.01384.x
- By:
- Publication type:
- Article
A Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE): an atopic dermatitis primary prevention study using emollients-protocol for a randomized controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 2, p. 238, doi. 10.1093/bjd/ljad124
- By:
- Publication type:
- Article